Rising Polypharmacy: Gabapentinoid-Opioid Co-Prescribing Soars Despite FDA Warnings, Posing Elevated Risks for Aging Population
A new study reveals a significant and concerning trend: the co-prescribing of gabapentinoids alongside long-term opioid therapy has surged over...
July 21, 2025